Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Sermorelin vs Other GHRH Analogs: Research Selection

Choosing between Sermorelin, CJC-1295 without DAC, and CJC-1295 with DAC comes down to what question the research design is asking: Use Sermorelin when: Research requires pulsatile GH stimulation that closely mimics natural GHRH physiology; receptor sensitivit

This comparison does not assign a generated winner or score.

  • Choosing between Sermorelin, CJC-1295 without DAC, and CJC-1295 with DAC comes down to what question the research design is asking:
  • Use Sermorelin when: Research requires pulsatile GH stimulation that closely mimics natural GHRH physiology; receptor sensitivity preservation is a priority; studying the aging GH axis where restoration of natural patterns is the research question; or using Sermorelin as a historical reference compound alongside newer analogs.
  • Use CJC-1295 without DAC when: Pulsatile GH release is still needed but a somewhat longer active period is preferable to Sermorelin's very brief window; studies are examining the DPP-IV-resistant GHRH signal.
  • Use CJC-1295 with DAC when: Maximal sustained GH elevation is the research goal; the experimental design benefits from extended dosing intervals; studying the effects of prolonged GH axis stimulation on body composition or metabolism over weeks.
  • None of these is "better" — each is appropriate for different research designs. The selection should follow the experimental question. View CJC-1295 with DAC | View CJC-1295 without DAC | View Sermorelin.
More references

Related material

Comparison

Route Comparison Summary

Intravenous (IV) 100% Immediate PK studies, acute GH response studies Subcutaneous (SC) ~40-70% 5-10 minutes Standard animal model studies Intranasal Low Variable Delivery route c…

View details →